We are live on ! Find out more
RFA

Reilly Financial Advisors Portfolio holdings

AUM $1.35B
1-Year Est. Return 22.65%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+22.65%
3 Year Est. Return
+99%
5 Year Est. Return
+129.17%
10 Year Est. Return
–
AUM
$578M
AUM Growth
+$14.5M
Cap. Flow
+$3.32M
Cap. Flow %
0.57%
Top 10 Hldgs %
21.43%
Holding
976
New
112
Increased
167
Reduced
159
Closed
112

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$9.63M
2
PYPL icon
PayPal
PYPL
+$9.15M
3
FDS icon
Factset
FDS
+$9.05M
4
TMO icon
Thermo Fisher Scientific
TMO
+$8.62M
5
JNJ icon
Johnson & Johnson
JNJ
+$8.19M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.88M
2
GILD icon
Gilead Sciences
GILD
+$8.83M
3
TTE icon
TotalEnergies
TTE
+$8.31M
4
EW icon
Edwards Lifesciences
EW
+$8.06M
5
NVO
Novo Nordisk
NVO
+$7.56M

Sector Composition

Rank Sector Weight
1 Financials 15.4%
2 Technology 13.32%
3 Consumer Discretionary 12%
4 Industrials 10.05%
5 Healthcare 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCUR
826
DELISTED
Macrocure Ltd.
MCUR
$1K ﹤0.01%
+1,000
New +$1.58K
DO
827
DELISTED
Diamond Offshore Drilling
DO
$1K ﹤0.01%
58
– –
ADM icon
828
Archer Daniels Midland
ADM
$38.2B
– –
-118
Closed -$5K
AIG icon
829
American International
AIG
$41.7B
$0 ﹤0.01%
5
-48
-91% -$3.01K
ALTO icon
830
Alto Ingredients
ALTO
$369M
$0 ﹤0.01%
1
– –
ASML icon
831
ASML
ASML
$626B
– –
-7,131
Closed -$781K
AUPH icon
832
Aurinia Pharmaceuticals
AUPH
$1.91B
$0 ﹤0.01%
+100
New +$322
AXR icon
833
AMREP Corp
AXR
$123M
$0 ﹤0.01%
+7,000
New +$51.6K
BAC.PRL icon
834
Bank of America Series L
BAC.PRL
$3.97B
– –
-3
Closed -$4K
BBU
835
DELISTED
Brookfield Business Partners
BBU
$0 ﹤0.01%
14
– –
BBY icon
836
Best Buy
BBY
$18.2B
– –
-84
Closed -$3K
BHC icon
837
Bausch Health
BHC
$2.58B
– –
-70
Closed -$2K
BKLN icon
838
Invesco Senior Loan ETF
BKLN
$6.97B
– –
-59
Closed -$1K
BOX icon
839
Box
BOX
$4.37B
– –
-500
Closed -$8K
CAG icon
840
Conagra Brands
CAG
$6.94B
– –
-643
Closed -$24K
CARM
841
DELISTED
Carisma Therapeutics
CARM
$0 ﹤0.01%
5
– –
CLDX icon
842
Celldex Therapeutics
CLDX
$2.99B
$0 ﹤0.01%
7
– –
CMC icon
843
Commercial Metals
CMC
$7.6B
$0 ﹤0.01%
20
– –
CNQ icon
844
Canadian Natural Resources
CNQ
$99.4B
– –
-613
Closed -$10K
CRDF icon
845
Cardiff Oncology
CRDF
$66.5M
– –
-35
Closed -$11K
CRMT icon
846
America's Car Mart
CRMT
$26.6M
– –
-400
Closed -$15K
DARE icon
847
Dare Bioscience
DARE
$18.3M
$0 ﹤0.01%
2
– –
DDD icon
848
3D Systems Corp
DDD
$431M
– –
-100
Closed -$2K
DMO
849
Western Asset Mortgage Opportunity Fund
DMO
$118M
– –
-425
Closed -$10K
DVAX
850
DELISTED
Dynavax Technologies
DVAX
$0 ﹤0.01%
30
– –
32 33
34
35 36

Similar funds

6M
6 Meridian Wichita, Kansas $1.37B AUM 17.3% 1-Year Est. Return
CCT
Country Club Trust Kansas City, Missouri $1.27B AUM 22.67% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
C
ConocoPhillips Houston, Texas $1.12B AUM 103.31% 1-Year Est. Return
TU
TDAM USA Toronto, Ontario, Canada $1.61B AUM 28.05% 1-Year Est. Return
CC
Cassaday & Co Mclean, Virginia $1.06B AUM 17.6% 1-Year Est. Return
RM
Resource Management Metairie, Louisiana $970M AUM 28.05% 1-Year Est. Return
EC
EMS Capital New York $944M AUM 17.76% 1-Year Est. Return

Reilly Financial Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Reilly Financial Advisors held 976 positions worth $578M, up 2.6% from $564M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Reilly Financial Advisors's Q4 2016 filing shows 112 new, 167 increased, 159 reduced and 112 closed positions. Its largest new stake was Factset: 56,738 shares worth $9.27M. The largest sale was CVS Health, an estimated $8.88M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Reilly Financial Advisors's largest Q4 2016 buy was Factset: 56,738 shares worth $9.27M.
  • Reilly Financial Advisors added most to Alibaba in Q4 2016, an estimated $9.63M increase.
  • Reilly Financial Advisors's biggest Q4 2016 reduction was CVS Health, cutting an estimated $8.88M.
  • Reilly Financial Advisors fully exited Novo Nordisk in Q4 2016, selling an estimated $7.56M.
  • Reilly Financial Advisors's ten largest holdings make up 21% of its $578M portfolio in Q4 2016.
  • Reilly Financial Advisors opened 112 new positions and closed 112 in Q4 2016.
  • Reilly Financial Advisors's portfolio value rose 2.6% quarter-over-quarter to $578M.

Based on Reilly Financial Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.